⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20102829 | 0.84 | — | — | |
| SCHEMBL19028874 | 0.84 | — | — | |
| SCHEMBL6977948 | 0.82 | CA1 (0.37) | — | |
| SCHEMBL27843139 | 0.74 | LMNA (0.31) | — | |
| SCHEMBL28529181 | 0.73 | — | — | |
| SCHEMBL463837 | 0.70 | — | — | |
| SCHEMBL21202576 | 0.70 | CA1 (0.34) | — | |
| SCHEMBL7736895 | 0.69 | LMNA (0.32) | — | |
| SCHEMBL24008051 | 0.67 | — | — | |
| SCHEMBL14665896 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102383-A1 | LPAR1 Inhibitors | ABBVIE INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-12583858-B2 | TDO2 inhibitors | GENENTECH, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| WO-2025226510-A1 | LPAR1 INHIBITORS | ABBVIE INC. (US) | 2025-10-30 | — | — | WO | disclosed |
| EP-4640274-A1 | LPAR1 INHIBITORS | AbbVie Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250282776-A1 | Bicyclic TLR7 Agonists and Uses Thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-09-11 | — | — | US | disclosed |
| US-12358887-B2 | IKAROS Zinc Finger Family degraders and uses thereof | GILEAD SCIENCES, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| EP-4464703-A2 | IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF | Gilead Sciences, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| EP-4245756-B1 | IKAROS ZINC FINGER FAMILY DEGRADERS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2024-10-09 | — | — | EP | disclosed |
| EP-3394068-B1 | TDO2 INHIBITORS | GENENTECH INC (US) | 2024-09-11 | — | — | EP | disclosed |
| CN-118480049-A | PKMYT1 inhibitor and preparation method and application thereof | 南京同诺康医药科技有限公司 | 2024-08-13 | — | — | CN | disclosed |
| US-20110152411-A1 | POLYMER COMPOSITION COMPRISING PHENOLIC RESIN | EVONIK DEGUSSA GMBH (DE) | 2011-06-23 | — | — | US | disclosed |
| US-20110152411-A1 | POLYMER COMPOSITION COMPRISING PHENOLIC RESIN | EVONIK DEGUSSA GMBH (DE) | 2011-06-23 | — | — | US | disclosed |
| CN-102066332-A | Process for the preparation of naphthalen-2-yl-pyrazol-3-one intermediates useful in the synthesis of sigma receptor inhibitors | ESTEVE LABOR DR | 2011-05-18 | — | — | CN | disclosed |
| WO-2009132924-A1 | POLYMER COMPOSITION COMPRISING PHENOLIC RESIN | EVONIK DEGUSSA GMBH (DE) | 2009-11-05 | — | — | WO | disclosed |
| WO-2009132923-A1 | CONTINUOUS PROCESS FOR PRODUCING A REACTIVE POLYMER | EVONIK DEGUSSA GMBH (DE) | 2009-11-05 | — | — | WO | disclosed |
| EP-0563328-B1 | Tc(III)-99m MYOCARDIAL IMAGING AGENTS AND METHOD OF USE | MALLINCKRODT MEDICAL INC (US) | 1999-06-30 | — | — | EP | disclosed |
| EP-0563328-A1 | ?99m Tc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE | MALLINCKRODT MEDICAL, INC. (US) | 1993-10-06 | — | — | EP | disclosed |
| WO-1992011040-A2 | 99mTc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE | MALLINCKRODT MEDICAL, INC. (US) | 1992-07-09 | — | — | WO | disclosed |
| US-5112595-A | Diaminoalkyldifuranones and phosphine ligands with technetium for imaging | MALLINCKRODT MEDICAL, INC. (US) | 1992-05-12 | — | — | US | disclosed |
| US-5112594-A | Diaminoalkyldifuranones and phosphine ligands with technetium for imaging | MALLINCKRODT MEDICAL, INC. (US) | 1992-05-12 | — | — | US | disclosed |